101 related articles for article (PubMed ID: 16299292)
21. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
[TBL] [Abstract][Full Text] [Related]
22. Leishmania donovani vs immunity: T-cells sensitized from Leishmania of one donor may modulate their cytokines pattern on re-stimulation with Leishmania from different donor in visceral leishmaniasis.
Narayan S; Bimal S; Singh SK; Gupta AK; Singh VP; Sinha PK; Das P
Exp Parasitol; 2009 Jan; 121(1):69-75. PubMed ID: 18948098
[TBL] [Abstract][Full Text] [Related]
23. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis.
Sharma SK; Dube A; Nadeem A; Khan S; Saleem I; Garg R; Mohammad O
Vaccine; 2006 Mar; 24(11):1800-10. PubMed ID: 16310900
[TBL] [Abstract][Full Text] [Related]
24. Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice.
Thakur A; Kaur H; Kaur S
Immunobiology; 2015 Sep; 220(9):1031-8. PubMed ID: 26001730
[TBL] [Abstract][Full Text] [Related]
25. An Excess of the Proinflammatory Cytokines IFN-γ and IL-12 Impairs the Development of the Memory CD8+ T Cell Response to Chlamydia trachomatis.
Zhang X; Starnbach MN
J Immunol; 2015 Aug; 195(4):1665-75. PubMed ID: 26179901
[TBL] [Abstract][Full Text] [Related]
26. Comparison of liposome based antigen delivery systems for protection against Leishmania donovani.
Bhowmick S; Mazumdar T; Sinha R; Ali N
J Control Release; 2010 Jan; 141(2):199-207. PubMed ID: 19818373
[TBL] [Abstract][Full Text] [Related]
27. Marginal zone B cells regulate antigen-specific T cell responses during infection.
Bankoti R; Gupta K; Levchenko A; Stäger S
J Immunol; 2012 Apr; 188(8):3961-71. PubMed ID: 22412197
[TBL] [Abstract][Full Text] [Related]
28. T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani.
Hailu A; van Baarle D; Knol GJ; Berhe N; Miedema F; Kager PA
Clin Immunol; 2005 Nov; 117(2):182-91. PubMed ID: 16125466
[TBL] [Abstract][Full Text] [Related]
29. Epitope mapping and protective immunity elicited by adenovirus expressing the Leishmania amastigote specific A2 antigen: correlation with IFN-gamma and cytolytic activity by CD8+ T cells.
Resende DM; Caetano BC; Dutra MS; Penido ML; Abrantes CF; Verly RM; Resende JM; Piló-Veloso D; Rezende SA; Bruna-Romero O; Fernandes AP; Gazzinelli RT
Vaccine; 2008 Aug; 26(35):4585-93. PubMed ID: 18588933
[TBL] [Abstract][Full Text] [Related]
30. CD8(+) T cells with parasite-specific cytotoxic activity and a Tc1 profile of cytokine and chemokine secretion develop in experimental visceral leishmaniasis.
Tsagozis P; Karagouni E; Dotsika E
Parasite Immunol; 2003; 25(11-12):569-79. PubMed ID: 15053778
[TBL] [Abstract][Full Text] [Related]
31. Immunization with the Leishmania infantum recombinant cyclophilin protein 1 confers partial protection to subsequent parasite infection and generates specific memory T cells.
Santos-Gomes GM; Rodrigues A; Teixeira F; Carreira J; Alexandre-Pires G; Carvalho S; Santos-Mateus D; Martins C; Vale-Gato I; Marques C; Tomás AM
Vaccine; 2014 Mar; 32(11):1247-53. PubMed ID: 24486368
[TBL] [Abstract][Full Text] [Related]
32. Function of CD8+ T lymphocytes in a self-curing mouse model of visceral leishmaniasis.
Tsagozis P; Karagouni E; Dotsika E
Parasitol Int; 2005 Jun; 54(2):139-46. PubMed ID: 15866476
[TBL] [Abstract][Full Text] [Related]
33. Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection.
Tewary P; Pandya J; Mehta J; Sukumaran B; Madhubala R
FEMS Immunol Med Microbiol; 2004 Oct; 42(2):241-8. PubMed ID: 15364110
[TBL] [Abstract][Full Text] [Related]
34. CD40 expression levels modulate regulatory T cells in Leishmania donovani infection.
Martin S; Agarwal R; Murugaiyan G; Saha B
J Immunol; 2010 Jul; 185(1):551-9. PubMed ID: 20525887
[TBL] [Abstract][Full Text] [Related]
35. HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages.
Basu R; Roy S; Walden P
J Infect Dis; 2007 May; 195(9):1373-80. PubMed ID: 17397010
[TBL] [Abstract][Full Text] [Related]
36. Immune evasive mechanisms contributing to persistent Leishmania donovani infection.
Stäger S; Joshi T; Bankoti R
Immunol Res; 2010 Jul; 47(1-3):14-24. PubMed ID: 20087685
[TBL] [Abstract][Full Text] [Related]
37. Isolation of protective T cells from BALB/cJ mice chronically infected with Leishmania donovani.
Holaday B; Sadick MD; Pearson RD
J Immunol; 1988 Sep; 141(6):2132-7. PubMed ID: 3262649
[TBL] [Abstract][Full Text] [Related]
38. Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.
Breton M; Tremblay MJ; Ouellette M; Papadopoulou B
Infect Immun; 2005 Oct; 73(10):6372-82. PubMed ID: 16177308
[TBL] [Abstract][Full Text] [Related]
39. Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen.
Polley R; Stager S; Prickett S; Maroof A; Zubairi S; Smith DF; Kaye PM
Infect Immun; 2006 Jan; 74(1):773-6. PubMed ID: 16369038
[TBL] [Abstract][Full Text] [Related]
40. Acquisition of cell-mediated immunity to Leishmania. II. LSH gene regulation of accessory cell function.
Kaye PM; Patel NK; Blackwell JM
Immunology; 1988 Sep; 65(1):17-22. PubMed ID: 3141269
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
